Lir Therapeutics
PrivateTotal Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lir Therapeutics operates in Healthcare & Life Sciences and is based in London. It has raised $3M.
Lir Therapeutics is a biotechnology company that develops AI-driven viral-vector engineering technologies for gene therapy applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lir Therapeutics Comparables
Compare Lir Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WhiteLab Genomics | 86% | |
| Byongen Therapeutics | 86% | |
| Dyno Therapeutics | 86% |
For institutional investors. Book with your work email.
Lir Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lir Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cell and Gene Therapy Catapult | Seed |
| Amino Collective | Seed |
| Fly Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 62% MoM, from 1.8K to 2.9K.
- Jul 18, 2026
Grew 43% QoQ from 7 to 10 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 18, 2026
Lirtx and VectorBuilder announce a strategic collaboration to develop adeno-associated virus (AAV) capsids that combine strong biological performance with manufacturability and scalability, using AI-powered optimization from computational design through laboratory validation and manufacturing in Illinois on Aug 18th '26.
For institutional investors. Book with your work email.
Lir Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lir Therapeutics's valuation, stock price, and market status.
Is Lir Therapeutics a public or private company?
Lir Therapeutics is a private company.
What is the current stock price of Lir Therapeutics?
Lir Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lir Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lir Therapeutics worth (valuation)?
Valuation information for Lir Therapeutics is not publicly available.
Can I buy Lir Therapeutics stock?
Lir Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lir Therapeutics's last funding round?
Funding round information for Lir Therapeutics is not publicly available.
Who are the main investors in Lir Therapeutics?
Key investors in Lir Therapeutics include Cell and Gene Therapy Catapult, Amino Collective, Fly Ventures.
Will Lir Therapeutics IPO soon?
No public IPO plans have been announced for Lir Therapeutics.
How can I track Lir Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lir Therapeutics's shares on secondary markets.